NHS Evidence - Gastroenterology and liver diseases - Capecitabine for the treatment of advanced gastric cancer

Links shared publicly online about this topic.

981
total visits

NHS Evidence - Gastroenterology and liver diseases - Capecitabine for the treatment of advanced gastric cancer

Aims: This technology appraisal addresses the use of capecitabine for the treatment of advanced gastric cancer. Recommendations: Capecitabine in combination with a platinum-based regimen is recommended for the first-line treatment of inoperable advanced gastric cancer. Intended audience: Healthcare professionals. Methodology and Development: Section 4 'Consideration of the evidence' addresses the clinical and cost effectiveness of capecitabine for the treatment of advanced gastric cancer, and co

View full resource at library.nhs.uk

Tags: Gastroenterology, Liver, Cancer, Cancer Medication, Colorectal Cancer Medication, Stomach Cancer, Xeloda